Status:
RECRUITING
Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues
Lead Sponsor:
Methodist Health System
Conditions:
Outpatient Prescription Issues
Eligibility:
All Genders
Phase:
NA
Brief Summary
The study aims to document the utility of Methodist Charlton Medical Center (MCMC's)Emergency Medicine Pharmacist (EMP) Collaborative Practice Agreement (CPA )utilization for the resolution of outpati...
Detailed Description
Use of an EMP CPA, which allows for broad prescriptive authority, will assist Emergency Department (ED )workflow by preventing a significant volume of new prescriptions needing to be sent by physician...
Eligibility Criteria
Inclusion
- Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 and a progress note and documenting the reason for the call and action taken by the EMP.
Exclusion
- CPA actions were misclassified as discharge prescription issue resolutions.
- Patients with prescriptions pursuant to late culture review, formulation changes not requiring a new prescription, prescription transfers to another pharmacy, or simple retransmission of prescriptions.
- Patients documented to have left the ED against medical advice.
Key Trial Info
Start Date :
December 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06222424
Start Date
December 15 2023
End Date
December 15 2026
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Institute at Methodist Health System
Dallas, Texas, United States, 75203